Equities

Market movers

Constituents of the S&P 500 with the highest percent gain over one day.
ListingLastChangeVolume
CF Industries Holdings IncCF:NYQ47.88
USD
+1.71
+3.70%
2.23m
Advanced Micro Devices IncAMD:NSQ34.39
USD
+1.18
+3.55%
65.29m
Wynn Resorts LtdWYNN:NSQ137.77
USD
+3.88
+2.90%
2.64m
Gilead Sciences IncGILD:NSQ68.07
USD
+1.81
+2.73%
7.47m
Royal Caribbean Cruises LtdRCL:NYQ112.85
USD
+2.71
+2.46%
3.59m
Dow IncDOW:NYQ50.93
USD
+1.22
+2.45%
4.82m
Nielsen Holdings PLCNLSN:NYQ23.41
USD
+0.55
+2.41%
9.04m
Twitter IncTWTR:NYQ38.68
USD
+0.84
+2.22%
12.70m
Regeneron Pharmaceuticals IncREGN:NSQ298.20
USD
+5.64
+1.93%
847.45k
Alexion Pharmaceuticals IncALXN:NSQ123.04
USD
+2.22
+1.84%
928.97k
Data delayed at least 15 minutes, as of Jul 15 2019 21:01 BST.

Mergers and acquisitions

Mergers and acquisitions across all companies with an updated deal status over the last 90 days

CompaniesDeal statusDeal valueDate
United Technologies Corp acquired Raytheon CoAnnounced86.83bn USD09 Jun 2019
AbbVie Inc acquired Allergan PLCAnnounced62.12bn USD25 Jun 2019
Occidental Petroleum Corp acquired Anadarko Petroleum CorpAnnounced38.38bn USD24 Apr 2019
Global Payments Inc acquired Total System Services IncAnnounced21.99bn USD28 May 2019
Fiat Chrysler Automobiles NV acquired Regie Nationale Des Usines Renault SADeal withdrawn19.78bn USD27 May 2019
101 total results

Institutional Ownership

Company% of available shares heldNet share increase since last reportedValue of change
Rubicon Minerals CorpRMX:TOR10.62%+497,726.67%3.77m CAD
db Brent Crude Oil Booster Euro Hedged ETCXETC:FRA:EUR0.00%+30,000.00%14.34m EUR
PIMCO High Income FundPHK:NYQ0.02%+3,540.86%196.31k USD
ContraVir Pharmaceuticals IncCTRV:NAQ13.37%+1,352.89%1.90m USD
Direxion Daily Financial Bear 3X SharesFAZ:PCQ:USD0.18%+1,181.86%318.84k USD
iShares S&P 500 Consumer Staples Sector UCITS ETF USD (Acc)IUCS:LSE:USD0.00%-1.00%-386.59k USD
Aceto CorpACETQ:PKN0.00%-1.00%-21.50k USD
Siemens Healthineers AGSMMNY:PKC0.00%-1.00%-1.33k USD
GeoPark LtdGPRK:NYQ0.00%-1.00%-713.42k USD
Kiadis Pharma NVKDS:AEX0.00%-1.00%-583.77k EUR
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.